SAN JUAN, Puerto Rico, Feb. 01, 2018 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or the “Company”) announced today that it commenced construction on its fourth of five medicinal cannabis dispensary locations in Puerto Rico. Located in the Hato Rey district of San Juan, this is the newest location for which the Company has received pre-qualification for a dispensary license from the Department of Health or Puerto Rico.
Green Spirit’s newest dispensary is located at Calle César González #508, Hato Rey, Puerto Riuco 00918. San Juan‘s Hato Rey district includes a mix of both residential and commercial properties and is the city’s most densely populated district. The medicinal cannabis dispensary is located in a heavily trafficked area and is in close proximity to a large concentration of doctors’ offices and medical practices; most motably Clinica las Americas Medical Center and El Maestro Hospital. As part of the acquisition, completed in early January, Green Spirit assumed the dispensary’s building lease.
Like the Company’s other locations throughout Puerto Rico, this dispensary will offer patients an extensive selection of medicinal cannabis.
To date, the Company has completed construction at one of its dispensary locations and anticipates completing construction at its remaining locations by the end of the first quarter of 2018, with operations commencing thereafter upon receipt of the requisite operating permits from the DHPR. For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.
About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), together with its wholly-owned subsidiary, Project 1493, LLC, is in the business of acquiring, developing and operating medical cannabis dispensaries.
Forward-Looking Statements
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.
Contact:
Paul Gendreau
PGPR
[email protected]
678-807-7945


Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



